Furthermore, our study has demonstrated a novel regulatory pathway of SMAD3 in NSCLC cells, namely the SMAD3/ITGA6/PI3K/Akt signaling pathway, as illustrated in Fig. 10. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.